All In Biotech

Drug Trial Radar · NCT04385277

Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)

A Pilot Study of Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide in the Post-Consolidation Setting for High-Risk Neuroblastoma

Last checked: Nov 20, 2026Latest source record: Oct 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registry

Status

Active, not recruiting

Enrollment

41

Actual

Start

Dec 31, 2020

Primary completion

Jun 30, 2023

Study completion Sep 30, 2027

Sponsor

Lead sponsor
Children's Oncology GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI)
First posted
May 12, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, up to 30 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase II trial studies if dinutuximab, GM-CSF, isotretinoin in combination with irinotecan, and temozolomide (chemo-immunotherapy) can be given safely to patients with high-risk neuroblastoma after Consolidation therapy (which usually consists of two autologous stem cell transplants and radiation) who have not experienced worsening or recurrence of their disease. Dinutuximab represents a kind of cancer therapy called immunotherapy. Unlike chemotherapy and radiation, dinutuximab targets the cancer cells without destroying nearby healthy cells. Sargramostim helps the body produce normal infection-fighting white blood cells. Isotretinoin helps the neuroblastoma cells become more mature. These 3 drugs (standard immunotherapy) are already given to patients with high-risk neuroblastoma after Consolidation because they have been proven to be beneficial in this setting. Chemotherapy drugs, such as irinotecan and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. They may also affect how well immunotherapy works on neuroblastoma cells. Giving chemo-immunotherapy after intensive therapy may work better in treating patients with high-risk neuroblastoma compared to standard immunotherapy.

Conditions

  • Ganglioneuroblastoma, Nodular
  • Neuroblastoma

Interventions

  • Biospecimen CollectionProcedure

    Correlative studies

  • Bone Marrow AspirationProcedure

    Undergo BM aspiration

  • Bone Marrow BiopsyProcedure

    Undergo BM biopsy

  • Computed TomographyProcedure

    Undergo CT

  • DinutuximabBiological

    Given IV

  • FDG-Positron Emission TomographyProcedure

    Undergo FDG-PET

  • Iobenguane I-123Radiation

    Undergo 123I-MIBG

  • IrinotecanDrug

    Given IV

  • IsotretinoinDrug

    Given PO

  • Magnetic Resonance ImagingProcedure

    Undergo MRI

  • Multigated Acquisition ScanProcedure

    Undergo MUGA

  • SargramostimBiological

    Given SC or IV

  • TemozolomideDrug

    Given PO or via enteral tube

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Patients Who Complete 5 Cycles of Dinutuximab + Chemotherapy Without Progressive Disease (PD)Time frame: Within 30 weeks from the date of first treatment

Locations

77 sites in 4 countries. Site status is shown where the registry gives one.

  • Banner Children's at Desert

    Mesa, Arizona

  • Arkansas Children's Hospital

    Little Rock, Arkansas

  • Kaiser Permanente Downey Medical Center

    Downey, California

  • Children's Hospital Los Angeles

    Los Angeles, California

  • Kaiser Permanente-Oakland

    Oakland, California

  • Children's Hospital of Orange County

    Orange, California

  • UCSF Medical Center-Mission Bay

    San Francisco, California

  • Children's Hospital Colorado

    Aurora, Colorado

  • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center

    Denver, Colorado

  • Connecticut Children's Medical Center

    Hartford, Connecticut

  • Alfred I duPont Hospital for Children

    Wilmington, Delaware

  • Children's National Medical Center

    Washington D.C., District of Columbia

  • Golisano Children's Hospital of Southwest Florida

    Fort Myers, Florida

  • University of Florida Health Science Center - Gainesville

    Gainesville, Florida

  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital

    Hollywood, Florida

  • Nemours Children's Clinic-Jacksonville

    Jacksonville, Florida

  • Nemours Children's Hospital

    Orlando, Florida

  • Children's Healthcare of Atlanta - Egleston

    Atlanta, Georgia

  • Saint Luke's Cancer Institute - Boise

    Boise, Idaho

  • Lurie Children's Hospital-Chicago

    Chicago, Illinois

  • University of Illinois

    Chicago, Illinois

  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois

  • Saint Jude Midwest Affiliate

    Peoria, Illinois

  • Riley Hospital for Children

    Indianapolis, Indiana

  • University of Iowa/Holden Comprehensive Cancer Center

    Iowa City, Iowa

  • Norton Children's Hospital

    Louisville, Kentucky

  • Ochsner Medical Center Jefferson

    New Orleans, Louisiana

  • Walter Reed National Military Medical Center

    Bethesda, Maryland

  • Dana-Farber Cancer Institute

    Boston, Massachusetts

  • C S Mott Children's Hospital

    Ann Arbor, Michigan

  • Children's Hospitals and Clinics of Minnesota - Minneapolis

    Minneapolis, Minnesota

  • University of Mississippi Medical Center

    Jackson, Mississippi

  • Children's Mercy Hospitals and Clinics

    Kansas City, Missouri

  • Washington University School of Medicine

    St Louis, Missouri

  • Mercy Hospital Saint Louis

    St Louis, Missouri

  • Children's Hospital and Medical Center of Omaha

    Omaha, Nebraska

  • University of Nebraska Medical Center

    Omaha, Nebraska

  • Hackensack University Medical Center

    Hackensack, New Jersey

  • Morristown Medical Center

    Morristown, New Jersey

  • Albany Medical Center

    Albany, New York

Showing 40 of 77 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.